Our data are in accordance to previous studies demonstrating that MAO inhibitors, both MAO-A and MAO-B inhibitors, as well as pargyline and tranylcypromine, are able to inhibit the proliferation of prostate and breast cancer cells [14,15]. The gene discussed is MAOB; the disease is breast carcinoma.